Reimbursement of NVS’ Lovneox costs (from MNTA CC):
• Reimbursement by MNTA of NVS’ Lovenox development costs is capped at 50% of MNTA’s cash flow from Lovenox during each quarter and will be deducted from NVS’s cash payments to MNTA during the quarter.
• MNTA expects the entire amount owed to NVS will be repaid (as described above) within three quarters.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”